NSD1 mediates antagonism between SWI/SNF and polycomb complexes and is required for transcriptional activation upon EZH2 inhibition
Yiannis Drosos(St. Jude Children's Research Hospital), Charles W.M. Roberts(Harvard University), Taosheng Chen(St. Jude Children's Research Hospital), Shondra M. Pruett‐Miller(St. Jude Children's Research Hospital), Margaret E. Larsen(St. Jude Children's Research Hospital), Robert J. Mobley(St. Jude Children's Research Hospital), Samuel T. Peters(St. Jude Children's Research Hospital), Natarajan V. Bhanu(Washington University in St. Louis), Emma C. Beane(St. Jude Children's Research Hospital), Beisi Xu(St. Jude Children's Research Hospital), Sandeep Kumar Dhanda(St. Jude Children's Research Hospital), Sandi Radko-Juettner(St. Jude Children's Research Hospital), Jonathan Low(St. Jude Children's Research Hospital), Santhosh A. Upadhyaya(University of Michigan), David E. Root(Broad Institute), Jacquelyn Myers(University of Rochester), Benjamin A. García(Princeton University), Janet F. Partridge(St. Jude Children's Research Hospital), Federica Piccioni(Broad Institute), Xiaotu Ma(St. Jude Children's Research Hospital), Baranda S. Hansen(St. Jude Children's Research Hospital)
Cited by 53
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
|Journal of Clinical Investigation|2011|928